Search Results - Shaheen, Monaster

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Abstract CT117: Interim analysis of the Phase 2 clinical trial of the IDO pathway inhibitor indoximod in combination with pembrolizumab for patients with advanced melanoma

    Abstract CT117: Interim analysis of the Phase 2 clinical trial of the IDO pathway inhibitor indoximod in combination with pembrolizumab for patients with advanced melanoma by Zakharia, Yousef, McWilliams, Robert, Shaheen, Monaster, Grossman, Kenneth, Drabick, Joseph, Milhem, Mohammed, Rixie, Olivier, Khleif, Samir, Lott, Ryan, Kennedy, Eugene, Munn, David, Vahanian, Nicholas, Link, Charles

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    799 Durable responses and immune activation with intratumoral electroporation of pIL-12 plus pembrolizumab in actively progressing anti-PD-1 refractory advanced melanoma: KEYNOTE 695 interim data

    799 Durable responses and immune activation with intratumoral electroporation of pIL-12 plus pembrolizumab in actively progressing anti-PD-1 refractory advanced melanoma: KEYNOTE 6... by Fernandez-Penas, Pablo, Carlino, Matteo, Tsai, Katy, Atkinson, Victoria, Shaheen, Monaster, Sajeve, Thomas, Mihalcioiu, Catalin, Tom Van Hagen, Roberts-Thomson, Rachel, Haydon, Andrew, Mant, Andrew, Butler, Marcus, Daniels, Gregory, Buchbinder, Elizabeth, Hyngstrom, John, Moller, Mecker, Puzanov, Igor, Cowey, C Lance, Whitman, Eric, Ballesteros-Merino, Carmen, Jensen, Shawn, Fox, Bernard, Schmidt, Emmett, Krepler, Clemens, Diede, Scott, Browning, Erica, Hermiz, Reneta, Svenson, Lauren, Salazar, Jon, Lee, Jack, Baker, Christopher, Bannavong, Donna, Sell, Jendy, Kellie Malloy Foerter, Canton, David, Aung, Sandra, Twitty, Christopher, Algazi, Alain, Daud, Adil

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: